Lemaitre Vascular LMAT
NASDAQ LMAT
$84.45 -0.88 (-1.03%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)

Updated

Lemaitre Vascular (LMAT) reported Current Deferred Revenue of $188,000 for Q2 2019, down 80.2% from $951,000 a year earlier and down 48.9% from the prior quarter.

Analysis

Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019) Analysis & Trends

At the end of FY2018, Lemaitre Vascular posted Current Deferred Revenue of $552,000.

  • Per Business Quant data, the three quarters before Q2 2019 came in at $368,000 (Q1 2019), $552,000 (Q4 2018) and $752,000 (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Lemaitre Vascular 1.93 Bn 484.25 Mn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 188,000.00
Mar 31, 2019 368,000.00
Dec 31, 2018 552,000.00
Sep 30, 2018 752,000.00
Jun 30, 2018 951,000.00
API Access

Lemaitre Vascular Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LMAT&period=max&api_key=YOUR_API_KEY